Successful Management of Surgery and Chemotherapht for Breast Cancer Complicated by Idiopathic Thrombocytopenic Purpura Using Thrombopoietin Receptor Agonists—Report of Two Cases—

Key Points

• Successful management involved maintaining platelet counts above 100,000/μl during surgery and chemotherapy, enhancing patient outcomes.
• Case 1 featured a 47-year-old woman with ITP and breast cancer, treated with elthrombopag and prednisone for platelet stability.
• Case 2 included a 16-year-old ITP patient eventually diagnosed with breast cancer, who underwent surgery and received elthrombopag postoperatively.
• Use of thrombopoietin receptor agonists showcases a viable strategy for patients with ITP undergoing cancer treatment; further studies are warranted.